Schroder Investment Management Group’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-303,397
Closed -$3.4M 1240
2025
Q1
$3.4M Buy
+303,397
New +$3.4M ﹤0.01% 830